PTAB Issues Final Decision In Last of Seven Instituted IPRs

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
222
PTAB Issues Final Decision In Last of Seven Instituted IPRs Against Finjan Patents

EAST PALO ALTO, CA--(Marketwired - Apr 13, 2017) - Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity company, and its subsidiary Finjan, Inc. ("Finjan") announced that on April 11, 2017, the Patent Trial and Appeal Board ("PTAB") for the United States Patent & Trademark Office ("USPTO") issued a final written decision on instituted Inter Partes Reviews ("IPRs") filed by Palo Alto Networks, Inc. (IPR2016-00159) and joined by Blue Coat Systems, LLC, (IPR2016-01174). The consolidated proceedings related to challenges to certain claims of Finjan's U.S. Patent 8,677,494 (the "'494 Patent").

Conclusively identical to its previous final decision on a petition filed by Symantec (IPR2015-01892), also related to the '494 Patent, the PTAB determined that only three method claims (i.e., 1, 2, and 6) were unpatentable while nine system claims (i.e., 3-5, and 10-15) were not unpatentable. Substantively, to date, only 1 independent method claim has been invalidated through the IPR process. This most recent decision is the last of seven instituted IPR proceedings against Finjan's patents.

"This final decision by the PTAB represents an important milestone and metric of the durability and value of Finjan's cybersecurity patents," stated Julie Mar-Spinola, CIPO of Finjan Holdings, Inc. "Finjan's patents have overcome 46 original IPR petitions, totaling more than 70 administrative challenges. Of the seven instituted IPR proceedings and more than a dozen ex parte proceedings the portfolio remains remarkably unchanged. We believe this is a direct testament to the quality of Finjan's patented inventions and the focus on the merits that we maintain in vigorously defending these patents today."

Summary of IPRs Instituted

Patent and Case Number    Petitioner   Decision
U.S. Patent No. 8,141,154
IPR-2015-01979
  PANW joined by Symantec   Not unpatentable (no changes)
U.S. Patent No. 8,141,154
IPR2016-00151
  PANW joined by Symantec   Not unpatentable (no changes)
U.S. Patent No. 8,677,494
IPR2015-01892
  Symantec joined by Blue Coat   Mixed (3 method claims unpatentable, 1 independent claim)
US Patent No. 7,647,633
IPR2015-01974
  PANW joined by Blue Coat   Not unpatentable (no changes)
US Patent No. 8,225,408
IPR2015-02001
  PANW joined by Blue Coat   Not unpatentable (no changes)
US Patent No. 8,225,408
IPR2016-00157
  Consolidated with IPR2015-02001   Not unpatentable (no changes)
US Patent No. 8,677,494
IPR2016-00159
  PANW joined by Blue Coat   Identical outcome to IPR2015-01892

Finjan has pending district court actions or appeals against Palo Alto Networks, Inc., Symantec Corporation, Blue Coat Systems, LLC., FireEye, Inc., ESET and its affiliates, and Cisco Systems, Inc., relating to, collectively, more than 20 patents in the Finjan portfolio. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.

ABOUT FINJAN
Established nearly 20 years ago, Finjan is a globally recognized leader in cybersecurity. Finjan's inventions are embedded within a strong portfolio of patents focusing on software and hardware technologies capable of proactively detecting previously unknown and emerging threats on a real-time, behavior-based basis. Finjan continues to grow through investments in innovation, strategic acquisitions, and partnerships promoting economic advancement and job creation. For more information, please visit www.finjan.com.

Follow Finjan Holdings, Inc.:
Twitter: @FinjanHoldings
LinkedIn: linkedin.com/company/finjan
Facebook: http://www.facebook.com/FinjanHoldings

Cautionary Note Regarding Forward-Looking Statements
Except for historical information, the matters set forth herein that are forward-looking statements involve certain risks and uncertainties that could cause actual results to differ. Potential risks and uncertainties include, but are not limited to, Finjan's expectations and beliefs regarding Finjan's licensing program, the outcome of pending or future enforcement actions, the granting of Inter Partes Review (IPR) of our patents or an unfavorable determination pursuant to an IPR or other challenges at the USPTO of our patents, the enforceability of our patents, the cost of litigation, the unpredictability of our cash flows, our ability to expand our technology and patent portfolio, the continued use of our technologies in the market, our stock price, changes in the trading market for our securities, regulatory developments, general economic and market conditions, the market acceptance and successful business, technical and economic implementation of Finjan Holdings' intended operational plan; and the other risk factors set forth from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2016, and the Company's periodic filings with the SEC, copies of which are available free of charge at the SEC's website at www.sec.gov or upon request from Finjan Holdings, Inc. All forward-looking statements herein reflect our opinions only as of the date of this release. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Finjan Holdings undertakes no obligation, and expressly disclaims any obligation, to update forward-looking statements herein in light of new information or future events.

Investor Contact:
Vanessa Winter
Finjan
Valter Pinto
KCSA Strategic Communications
(650) 282-3245
investors@finjan.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 138

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 113

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Insta360 Tests Holiday Demand With $170 Gear Discounts

Updated Category News Views 161

A discount banner can reveal plenty about a hardware brand's priorities, and Insta360's latest Black Friday push is plainly built to put more of its ecosystem into customers' hands. The company is advertising savings of up to US$170 across cameras, gimbals, microphones, webcams, and accessories, with the promotion available for a limited time through its own store and...

Continue Reading
CustomerInsights.AI Fast 500 Nod Tests Its AI Model

Updated Category News Views 44

Pharma’s analytics mess is exactly where CustomerInsights.AI has chosen to make its stand. The Scottsdale company’s inclusion in Deloitte’s 2026 Technology Fast 500, announced November 19, is a useful signal that its pitch is finding buyers: life-sciences businesses want AI to do actual commercial work, not sit in a lab demo collecting dust. Still, a Fast 500 badge...

Continue Reading
Mimic Bets Virtual Patching Can Calm AI Patch Chaos

Updated Category News Views 16

Three ugly outages in four days can make even hardened technology buyers reconsider the sacred ritual of “patch immediately.” Mimic’s new Virtual Patching offering arrives squarely in that uncomfortable gap: a vulnerability is known, attackers may be moving fast, and the proper vendor update still needs testing before somebody detonates production. The company’s...

Continue Reading
Miami Office Puts Dubai Closer to U.S. Business Deal Flow

Updated Category News Views 68

Miami is not a random pin on a map; it is a deliberate front door to the Americas, and Dubai International Chamber has decided it needs someone standing in it. The chamber opened a representative office there on November 19, 2026, its second in the United States after launching in New York during the Dubai Business Forum – USA in November 2025. This is not the sort of...

Continue Reading
ROHM's GaN PFC Chip Targets the Power-Supply Squeeze

Updated Category News Views 118

Power supplies are where a lot of sleek electronics quietly lose the plot, and ROHM is taking a proper swing at that problem. Its new BM85060FV is a totem-pole power factor correction controller built for gallium nitride, or GaN, high-frequency switching in AC-DC power supplies. The headline is not subtle: ROHM says a 300 to 500 W system using the chip can reach 99%...

Continue Reading
Eight O'Clock Adds Blonde Roast Pods to Its Lineup

Updated Category News Views 144

A lighter cup of coffee just became Eight O'Clock Coffee's newest swing at the single-serve shelf. On Nov. 19, 2026, the company said it introduced Blonde Roast K-Cup pods, a bright and smooth option aimed at drinkers who prefer a lighter roast. The product is available through Keurig.com and Amazon. That is the whole announcement, and frankly it is better to keep it that...

Continue Reading
RBI Heads to Morgan Stanley With Plenty to Explain

Updated Category News Views 53

Two executives, one New York stage, and a short calendar gap give Restaurant Brands International a clean chance to address investors without the usual blizzard of quarterly slides. Chief Executive Officer Josh Kobza and Chief Financial Officer Sami Siddiqui are scheduled for a fireside chat at Morgan Stanley's Global Consumer & Retail Conference on December 2, 2026, at...

Continue Reading
LiberNovo's Black Friday Chair Sale Tests Premium Demand

Updated Category News Views 102

Ergonomic chairs are not impulse purchases, and LiberNovo knows it. Its Black Friday push in the United States and Canada runs through November 30, throwing discounts, gifts, prize-wheel entries and loyalty points at buyers considering a fairly expensive piece of office equipment. That is a lot of promotional machinery for a chair sale, but the underlying pitch is...

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Unveils New Wealth Management Tools for Advisors

Updated Category News Views 212

Orion Unveils New Wealth Management Tools for Advisors Orion, known for empowering financial advisors with cutting-edge wealth management solutions, is excited to announce a series of significant enhancements aimed at assisting advisors in servicing high-net-worth (HNW) and ultra-high-net-worth (UHNW) clientele. As new economic paradigms shift with generational wealth...

Continue Reading
Myriad Genetics Enhances Breast Cancer Research with Collaborations

Updated Category News Views 119

Myriad Genetics Expands Research Collaborations for Breast Cancer Testing Myriad Genetics, Inc. (NASDAQ: MYGN), a pioneer in genetic testing and precision medicine, has recently embarked on a series of important research collaborations aimed at studying the application of molecular residual disease (MRD) testing in breast cancer. These initiatives leverage Myriad’s...

Continue Reading
Man Group PLC Discloses Significant Position in American Axle

Updated Category News Views 158

Significant Position Disclosure by Man Group PLC Man Group PLC, a global investment management firm, has made a notable disclosure concerning its significant interests in American Axle & Manufacturing Holdings, Inc. This disclosure falls under Rule 8.3 of the UK Takeover Code, which mandates disclosure by entities holding 1% or more of relevant securities in any company...

Continue Reading
Legal Protection Steps for Jasper Therapeutics Investors

Updated Category News Views 223

Understanding the Importance of Legal Counsel Deciding to invest in a company like Jasper Therapeutics, Inc. (NASDAQ: JSPR) can be a significant move, but it's crucial to be aware of the potential challenges that come with investing in securities. Individuals who have bought shares in Jasper Therapeutics between certain dates should pay close attention to upcoming...

Continue Reading
TotalEnergies Expands on Gas Strategy with Latest Acquisition

Updated Category News Views 124

TotalEnergies Expands on Gas Strategy with Latest Acquisition TotalEnergies SE (TTE) shares have shown an upward trend, particularly in premarket trading. Recently, the company announced a notable agreement with Lewis Energy Group that involves acquiring a significant 45% stake in its dry gas-producing assets located in the Eagle Ford Basin, Texas. Details of the...

Continue Reading